| Q37766138 | Advances in gene-based therapy for heart failure |
| Q36837270 | Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy |
| Q39366514 | Cardiac Calcium ATPase Dimerization Measured by Cross-Linking and Fluorescence Energy Transfer |
| Q34409721 | Cardiac Gene Therapy |
| Q37811189 | Cardiac gene therapy with SERCA2a: From bench to bedside |
| Q38677208 | Ca²⁺-induced delayed afterdepolarizations are triggered by dyadic subspace Ca2²⁺ affirming that increasing SERCA reduces aftercontractions |
| Q64377344 | Cell-specific expression of SERCA, the exogenous Ca2+transport ATPase, in cardiac myocytes |
| Q64377359 | Contractile effects of adenovirally-mediated increases in SERCA2a activity: a comparison between adult rat and rabbit ventricular myocytes |
| Q50102490 | Dependence of exogenous SERCA gene expression on coxsackie adenovirus receptor levels in neonatal and adult cardiac myocytes |
| Q37299072 | Designing heart performance by gene transfer. |
| Q36596746 | From gene therapy and stem cells to clinical electrophysiology |
| Q34130135 | Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation |
| Q33804951 | Gene therapies for arrhythmias in heart failure |
| Q36786243 | Gene therapy in the treatment of heart failure |
| Q38416938 | Gene therapy to restore electrophysiological function in heart failure |
| Q35724614 | Gene transfer in cardiac myocytes. |
| Q36050486 | Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications |
| Q38099580 | Genetic prediction of heart failure incidence, prognosis and beta-blocker response |
| Q35037543 | Heart failure -- a challenge to our current concepts of excitation-contraction coupling |
| Q39508627 | Hydralazine-induced promoter demethylation enhances sarcoplasmic reticulum Ca2+ -ATPase and calcium homeostasis in cardiac myocytes |
| Q42527073 | Interaction between increased SERCA2a activity and beta -adrenoceptor stimulation in adult rabbit myocytes. |
| Q47350552 | Interplay between SERCA and sarcolemmal Ca2+ efflux pathways controls spontaneous release of Ca2+ from the sarcoplasmic reticulum in rat ventricular myocytes |
| Q36856383 | Intracellular Ca alternans: coordinated regulation by sarcoplasmic reticulum release, uptake, and leak |
| Q89805347 | Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study |
| Q64378680 | Overexpression of SERCA2a accelerates repolarisation in rabbit ventricular myocytes |
| Q50750098 | Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814. |
| Q37396106 | Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice |
| Q40082023 | Prevention of Atrial Fibrillation by Using Sarcoplasmic Reticulum Calcium ATPase Pump Overexpression in a Rabbit Model of Rapid Atrial Pacing. |
| Q34627450 | Progesterone modulates SERCA2a expression and function in rabbit cardiomyocytes |
| Q43216744 | Reduced SERCA2 abundance decreases the propensity for Ca2+ wave development in ventricular myocytes |
| Q36562746 | Regulation of the sarcoplasmic reticulum Ca2+-ATPase expression in the hypertrophic and failing heart |
| Q37054922 | Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation |
| Q37248371 | Ryanodine receptor-mediated arrhythmias and sudden cardiac death. |
| Q37418216 | SERCA2a gene therapy in heart failure: an anti-arrhythmic positive inotrope. |
| Q37676218 | Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure |
| Q38016716 | Sarcoplasmic reticulum and calcium cycling targeting by gene therapy |
| Q40401079 | Sex-dependent alterations of Ca2+ cycling in human cardiac hypertrophy and heart failure |
| Q37878086 | Targeted gene therapy for the treatment of heart failure |
| Q37290746 | Targeting calcium handling in arrhythmias |
| Q40199219 | Treatment of heart failure by calcium cycling gene therapy |
| Q80106735 | [Rationale and clinical evidence for the effects of new pharmacological treatments for heart failure] |